Access to Millions of Visitor Simple Sign Up - Start Immediately

Covidien-brand heparin syringes recalled


Published: April 2, 2008 at 11:55 AM
Print story
Email to a friend
Font size:
WASHINGTON, April 2 (UPI) -- The U.S. Food and Drug Administration announced the recall of 32 lots of Covidien-brand pre-filled heparin syringes because of possible contamination.

Covidien, formerly Tyco Healthcare, initiated the voluntary recall after its supplier, Scientific Protein Laboratories LLC, said it had identified a heparin-like contaminant in the syringes.

The FDA said it had received reports of serious injuries and/or deaths in patients who have been administered heparin injectable products of other companies containing the same contaminant. Typical symptoms included anaphylactic-like reactions such as low blood pressure, shortness of breath, nausea, vomiting, diarrhea and abdominal pain.

The FDA said customers who have the recalled product in their possession should discontinue use immediately. Customers can obtain return-refund instructions from Covidien at 800-346-7197, ext. 8677.

The recalled syringe model and lot numbers are available at http://investor.covidien.com/phoenix.zhtml?c=207592&p=irol-newsArticle&ID=1123186&highlight=.

© 2008 United Press International. All Rights Reserved.
This material may not be reproduced, redistributed, or manipulated in any form.
Print story
Order reprints
Email to a friend
Post comment
See Also:
» Next in Science: FDA ultrasound contrast warning criticized

NASA DISCOVERY SPACE SHUTTLE
A crane lowers space shuttle Discovery toward the external tank and solid rocket boosters already stacked on the mobile launcher platform in high bay 3 of the Vehicle Assembly Building at Kennedy Space Center, Flordia. The stacking and mating took place in preparation for the launch on the STS-124 mission to the International Space Station, targeted to launch on May 31, 2008. (UPI Photo/Jim Grossmann/NASA)
Space Shuttle Discovery set to launch on May 31
Full Photo | Slideshow